Introduction Neuromodulation devices are cutting-edge therapeutic tools that modulate nerve activity by delivering precise electrical im ...

One major underdiscussed issue this year was the Biden administration’s failure to enforce a 2023 U.S. District Court for the ...

A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with ...

Its CYB003 is a deuterated psiloCybin analog that treats major depressive disorder and alcohol use disorder ... GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how ...

Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Major Depressive Disorder.

The study focused on 78 participants diagnosed with major depressive disorder who also had strong suicidal thoughts ... Its ...

Seasonal Affective Disorder (SAD) is a type of depression that occurs during in winter. With over 10 million cases in India, ...

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

Transcranial magnetic stimulation for alcohol use disorders is under investigation. Research to date suggests TMS could play ...

People with severe, treatment-resistant depression who received a nerve-stimulating therapy showed significant improvement in ...